12:00 AM
 | 
Apr 08, 2013
 |  BC Week In Review  |  Company News  |  Deals

AnGes, Nippon Zoki Pharmaceutical deal

AnGes granted Nippon Zoki exclusive, Japanese development and commercialization rights to NF-kappa B decoy to treat lower back pain and disk degeneration. AnGes...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >